2-(1H-pyrazol-5-yl)ethane-1,1,2-tricarboxylic acid

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 2-(1H-pyrazol-5-yl)ethane-1,1,2-tricarboxylic acid
• 化学式: C₈H₈N₂O₆
• 分子量: 228.16
• InChiKey: YSDNBVMWIZCTPX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1
• 重原子数：
  16
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  141
• 氢给体数：
  4
• 氢受体数：
  7

文献信息

• COMPOUNDS ACT AT MULTIPLE PROSTAGLANDIN RECEPTORS GIVING A GENERAL ANTI-INFLAMMATORY RESPONSE
  申请人：ALLERGAN, INC.

  公开号：EP2945932A1

  公开（公告）日：2015-11-25
• [EN] COMPOUNDS ACT AT MULTIPLE PROSTAGLANDIN RECEPTORS GIVING A GENERAL ANTI-INFLAMMATORY RESPONSE<br/>[FR] COMPOSÉS AYANT UN EFFET SUR PLUSIEURS RÉCEPTEURS DES PROSTAGLANDINES ET PRODUISANT UNE RÉPONSE ANTI-INFLAMMATOIRE GÉNÉRALE
  申请人：ALLERGAN INC

  公开号：WO2014113814A1

  公开（公告）日：2014-07-24

  The present invention provides a compound, that is a 1-[(2-[(alkyl or aryl)methyl]oxy}halo or haloalkyl substituted-phenyl)alkyl]-5-hydrocarbyl or substituted hydrocarbyl-1H-pyrazole carboxylic acid or alkylenylcarboxylic acid or a hydrocarbyl or substituted hydrocarbyl sulfonamide of said carboxylic acid or said alkylenylcarboxylic acid, provided however said compound is not a 3-carboxylic acid, a sulfonamide thereof, or a 3-methylenylcarboxylic acid. The compound may be represented by the following formula, wherein R1, R2, R3, R4, R5, R6, X, W, X and Y are as defined in the specification. The compounds may be administered to treat DP1, FP, EP1, TP and/or EP4 receptor mediated diseases or conditions.